Calcitriol for postmenopausal osteoporosis

Research output: Contribution to journalComment/debate

1 Citation (Scopus)

Abstract

Calcitriol has not been approved for the treatment of osteoporosis by the Food and Drug Administration. We do not claim that efficacy and safety have been demonstrated, but only that the findings are unclear enough to warrant continued investigation. For example, a recent two center, place-controlled study found that 3 years of treatment with calcitriol of women with postmenopausal osteoporosis resulted in a highly significant 65% reduction of vertebral fracture rate.

Original languageEnglish
Pages (from-to)621
Number of pages1
JournalAnnals of Internal Medicine
Volume111
Issue number7
StatePublished - 1989

Fingerprint

Postmenopausal Osteoporosis
Calcitriol
Fracture Fixation
United States Food and Drug Administration
Osteoporosis
Safety
Therapeutics

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Calcitriol for postmenopausal osteoporosis. / Gallagher, John Christopher G.; Riggs, B. L.

In: Annals of Internal Medicine, Vol. 111, No. 7, 1989, p. 621.

Research output: Contribution to journalComment/debate

@article{f56804a4a46646e2a1aca75bc1a2c4e4,
title = "Calcitriol for postmenopausal osteoporosis",
abstract = "Calcitriol has not been approved for the treatment of osteoporosis by the Food and Drug Administration. We do not claim that efficacy and safety have been demonstrated, but only that the findings are unclear enough to warrant continued investigation. For example, a recent two center, place-controlled study found that 3 years of treatment with calcitriol of women with postmenopausal osteoporosis resulted in a highly significant 65{\%} reduction of vertebral fracture rate.",
author = "Gallagher, {John Christopher G.} and Riggs, {B. L.}",
year = "1989",
language = "English",
volume = "111",
pages = "621",
journal = "Annals of Internal Medicine",
issn = "0003-4819",
publisher = "American College of Physicians",
number = "7",

}

TY - JOUR

T1 - Calcitriol for postmenopausal osteoporosis

AU - Gallagher, John Christopher G.

AU - Riggs, B. L.

PY - 1989

Y1 - 1989

N2 - Calcitriol has not been approved for the treatment of osteoporosis by the Food and Drug Administration. We do not claim that efficacy and safety have been demonstrated, but only that the findings are unclear enough to warrant continued investigation. For example, a recent two center, place-controlled study found that 3 years of treatment with calcitriol of women with postmenopausal osteoporosis resulted in a highly significant 65% reduction of vertebral fracture rate.

AB - Calcitriol has not been approved for the treatment of osteoporosis by the Food and Drug Administration. We do not claim that efficacy and safety have been demonstrated, but only that the findings are unclear enough to warrant continued investigation. For example, a recent two center, place-controlled study found that 3 years of treatment with calcitriol of women with postmenopausal osteoporosis resulted in a highly significant 65% reduction of vertebral fracture rate.

UR - http://www.scopus.com/inward/record.url?scp=0024394159&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024394159&partnerID=8YFLogxK

M3 - Comment/debate

VL - 111

SP - 621

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

SN - 0003-4819

IS - 7

ER -